News
Successful immune tolerance induction (ITI) in hemophilia A patients with inhibitors led to lower treatment costs, a study ...
Columnist Jennifer Lynne argues that her health is not defined by her diagnoses, and in fact those terms can often be too limited.
Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.
Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...
Speak up, trust your intuition, and never be afraid to ask questions.
Early diagnosis allows for timely preventive treatment and reduces the need for intensive factor replacement therapy in ...
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...
Columnist G Shellye Horowitz chats with four women about their struggles to obtain a von Willebrand disease diagnosis.
While packing for a move, columnist Joe MacDonald marvels at the differences between his two sons' experiences with hemophilia.
In the last of a series, columnist Jennifer Lynne talks with Chip Hailey about how gene therapy has transformed his life with hemophilia B.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results